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Abstract
Background: The requirements for growth and survival of the intracellular pathogen Trypanosoma
cruzi within mammalian host cells are poorly understood. Transcriptional profiling of the host cell
response to infection serves as a rapid read-out for perturbation of host physiology that, in part,
reflects adaptation to the infective process. Using Affymetrix oligonucleotide array analysis we
identified common and disparate host cell responses triggered by T. cruzi infection of phenotypically
diverse human cell types.
Results: We report significant changes in transcript abundance in T. cruzi-infected fibroblasts,
endothelial cells and smooth muscle cells (2852, 2155 and 531 genes respectively; fold-change ≥ 2,
p-value < 0.01) 24 hours post-invasion. A prominent type I interferon response was observed in
each cell type, reflecting a secondary response to secreted cytokine in infected cultures. To identify
a core cytokine-independent response in T. cruzi-infected fibroblasts and endothelial cells transwell
plates were used to distinguish cytokine-dependent and -independent gene expression profiles.
This approach revealed the induction of metabolic and signaling pathways involved in cell
proliferation, amino acid catabolism and response to wounding as common themes in T. cruzi-
infected cells. In addition, the downregulation of genes involved in mitotic cell cycle and cell division
predicted that T. cruzi infection may impede host cell cycle progression. The observation of
impaired cytokinesis in T. cruzi-infected cells, following nuclear replication, confirmed this
prediction.
Conclusion: Metabolic pathways and cellular processes were identified as significantly altered at
the transcriptional level in response to T. cruzi infection in a cytokine-independent manner. Several
of these alterations are supported by previous studies of T. cruzi metabolic requirements or effects
on the host. However, our methods also revealed a T. cruzi-dependent block in the host cell cycle,
at the level of cytokinesis, previously unrecognized for this pathogen-host cell interaction.
Background
Establishment of infection by intracellular pathogens
involves appropriation of host cell functions to facilitate
host cell entry, trafficking to specific intracellular loca-
tions and for nutrient acquisition [1-5]. Changes in host
cell gene expression that accompany the infection process
Published: 29 May 2009
BMC Genomics 2009, 10:252 doi:10.1186/1471-2164-10-252
Received: 4 December 2008
Accepted: 29 May 2009
This article is available from: http://www.biomedcentral.com/1471-2164/10/252
© 2009 Costales et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
Page 2 of 17
(page number not for citation purposes)
are highly dynamic and reflect a wide array of responses to
a specific host-pathogen relationship [6]. As such, tran-
scriptional profiling is frequently used as a genome-wide
tool to screen for the impact of pathogens on host cell
functions [7-11]. However, deciphering the biological
information contained within transcriptional response
data is a major challenge in host-pathogen studies [12].
Transcriptional response data provide valuable insights
into pathogen-triggered host defense pathways and
changes in expression of host cell metabolic genes during
infection, the transcriptional outcomes of such events are
often obscured by compounded responses to diffusible
molecules released by infected or neighboring cells. The
ability to identify gene expression changes that occur
independently of cytokines and other diffusible mole-
cules provides a first step toward revealing transcriptional
changes that report the more intimate host-pathogen
interaction, and to providing novel insights into physical
and biochemical impact of infection. In this study, we
have carried out a comparative analysis of host cell tran-
scriptional response to the intracellular protozoan para-
site,  Trypanosoma cruzi, in three phenotypically diverse
mammalian cell types with a view to uncovering a com-
mon signature response to parasite infection. We coupled
this approach with the use of a transwell plating system to
permit the identification of cytokine-dependent and -
independent responses to this pathogen.
T. cruzi, is the causative agent of human Chagas' disease
that affects several million people in South and Central
America [13]. Clinical manifestations arise during chronic
Chagas' disease and are the result of damage of the car-
diac, digestive and/or nervous systems [14]. While the
basis for the diverse organ disease patterns has not been
elucidated, differential cellular susceptibility to infection,
coupled with the nature of the host response elicited in
infected cells are likely to influence disease outcome. Try-
pomastigotes, the tissue invasive forms of T. cruzi, are
capable of establishing infection within in a variety of
nucleated cell types, including professional phagocytes
[15] and non-phagocytic cells, such as cardiomyocytes,
striated and smooth muscle cells, endothelial cells, adi-
pocytes and neurons [16-19]. To promote entry into non-
phagocytic cell types, T. cruzi trypomastigotes activate of a
number of host cell signaling pathways, including cal-
cium-dependent signaling [20-22], adenylyl cyclase [23],
phosphatidylinositol 3-kinases [24,25] and protein tyro-
sine kinases [26,27]. These early signaling events are
thought to orchestrate the host cellular events required for
invasion, such as actin microfilament remodeling [28] as
well as plasma membrane invagination [29] and targeted
lysosome fusion [30,31] that are involved in the forma-
tion of the parasitophorous vacuole. T. cruzi escapes the
vacuole several hours after entry resulting in cytosolic
localization of the parasite where transformation to the
replicative amastigote stage is completed by 24 hours
[32,33]. Over the course of 3–5 days cytosolic amastigotes
divide every 12 hours giving rise to several dozen intracel-
lular parasites.
Intracellular growth and persistence of T. cruzi amastig-
otes within a range of host cell types in vivo represents an
important target for therapeutic intervention, however,
little is known regarding the requirements for intracellular
growth of T. cruzi in mammalian cells. Similar to other
kinetoplastid protozoan parasites, T. cruzi is a purine aux-
otroph [34] that can utilize both glucose and amino acids
as a carbon source [35]. The inability of T. cruzi to synthe-
size leucine, isoleucine and valine [36] predicts that these
aliphatic amino acids are also scavenged from the host. To
investigate the impact of intracellular T. cruzi infection on
host cell gene expression, we compared the global tran-
scriptional response elicited by infection in three different
cell types. We find that approximately one-third of the
transcriptional changes observed in T. cruzi-infected cells
at 24 hours post infection, were initiated by cytokines and
other diffusible molecules released by infected tissue cul-
tures. The core cytokine-independent response elicited in
fibroblasts and endothelial cells underscore metabolic
and signaling pathways involved in cell proliferation,
amino acid catabolism and response to wounding. Fur-
thermore, the overall dampening of host cell genes related
to the mitotic cell cycle and cell division, suggested that T.
cruzi infection impedes cell cycle progression in the host
cell. This prediction was confirmed with the observation
of parasite-containing multinucleate cells arising in T.
cruzi-infected cultures, indicative of a failure to undergo
cytokinesis following nuclear replication. Overall, our
findings validate the use of transcriptional profiling in
conjunction with transwell plates to provide novel
insights into biological processes that are modulated in
infected host cells in a cytokine-independent manner.
Results
T. cruzi elicits a robust cytokine-dependent response in 
diverse cell types
To reveal a signature response elicited by Trypanosoma
cruzi in phenotypically diverse non-phagocytic mamma-
lian cell types, RNA was prepared from mock- and para-
site-infected human vascular smooth muscle cells
(VSMC), human microvascular endothelial cells
(HMVEC) and human foreskin fibroblasts (HFF) at 24
hours post-infection and prepared for hybridization to
HG_U133 plus 2.0 Affymetrix arrays for analysis of over
47,000 transcripts. VSMC were found to be less responsive
to T. cruzi infection than HFF or HMVEC where the aver-
age number of gene expression changes observed in two
independent experiments was as follows: VSMC: 531
genes (408 up, 131 down); HFF: 2852 genes (1204 up,
1648 down) and HMVEC 2155 genes (790 up, 1365BMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
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down) (Figure 1A; see Additional file 1: Table S1, Addi-
tional file 2: Table S2, and Additional file 3: Table S3)
where differences in the level of infection achieved in each
cell type (VSMC: ~75% infected; HFF: ~70% and HMVEC:
~55%) did not obviously correlate with the range or
intensity of the transcriptional response in each cell type.
No gross variation between the trypomastigote to amas-
tigote transition rate that could account for these differ-
ences among cell lines was evident either. The intersection
of gene sets representing induced genes in the three cell
types revealed 299 genes (Figure 1B; genes; see Additional
file 4: Table S4). Furthermore, intersecting the GO func-
tions induced in the three cell types, revealed 41 common
GO function categories (Figure 1B; GO functions; see Addi-
tional file 5: Table S5). Within this common set of genes,
interferon-stimulated genes (ISGs) including IFN-stimu-
lated exonuclease (ISG20), 2,5-oligoadenylate synthase
(OAS1) and myxovirus resistance protein (MX1), featured
as among the most highly expressed in parasite-infected
VSMC, HFF, and HMVEC (see Additional file 1: Table S1,
Additional file 2: Table S2 and Additional file 3: Table S3,
respectively). As a reflection of the robust induction of
ISGs, 'IFN-signaling' was identified as the top signaling
pathway induced by T. cruzi in infected cells (Figure 1C)
consistent with the marked increase in IFNβ expression in
all cell types (Figure 1D).
Dissecting the global host cell transcriptional response to 
T. cruzi
While the induction of cytokines and the cytokine-
dependent response in infected host cells provides impor-
tant information regarding the nature of the innate
immune response to T. cruzi, gene expression changes
occurring in a cytokine-independent manner are pre-
dicted to more directly report the impact of intracellular
parasitism. In addition to IFNβ, T. cruzi triggers the expres-
sion of cytokines such as IL-6, IL-8, IL-11 and IL-15 in host
cells (see Additional file 6: Table S6), which are predicted
to contribute to the global transcriptional response to this
pathogen. To discriminate between cytokine-dependent
and cytokine-independent responses to T. cruzi, a tran-
swell plating system was adopted to experimentally dis-
sect the global transcriptional response in HFF and
HMVEC. In this setup, cells in the top chamber serve as
reporters for the effect of cytokines and other diffusible
factors (herein referred to as 'cytokines' for simplicity)
secreted by parasite-infected cells in the bottom chamber
(Figure 2A). (VSMC were omitted from the transwell
experiments due to difficulties obtaining adequate RNA
from cells plated on the top chamber.) As predicted, cells
exposed only to secreted cytokines and diffusible products
(Figure 2A, B, Top) generated by the infected cell popula-
tion (Figure 2A, B, Bottom) responded with significant
changes in gene expression. The cytokine-responsive
genes represent a substantial fraction of the total number
of genes modulated in infected cells: 28% in HFF (803 of
2852 genes) and 22% in HMVEC (488 of 2155 genes).
To arrive at a subset of cytokine-independent gene
changes, the cytokine-responsive genes (Figure 2B, Top)
were filtered from the set of genes changing ≥ 2-fold in
parasite-infected cells (Figure 2B, Bottom) as displayed
(Figure 2B, Bottom-Top; (see Additional files 7: Tables S7
and Additional files 8: Table S8 for gene lists). The result-
ant heat map clearly shows that a large number of genes,
including those annotated as IFN-responsive, were
removed by this filtering step (see Additional files 7:
Tables S7 and Additional files 8: Table S8). In addition,
the biological pathways corresponding to 'IFN signaling',
'antigen presentation' and 'protein ubiquitination' that
featured prominently in the overall transcriptional
response to T. cruzi (Figure 1C), are no longer represented
as part of a significant cytokine-independent response in
HFF and HMVEC (Figure 3A). Quantitative RT-PCR
(qPCR) was used to confirm some of the cytokine-
dependent and -independent predictions from the micro-
array analysis with excellent concordance (Figure 2C). Of
note, many of the cytokine and chemokine genes induced
upon infection (eg. IFNβ, IL-8, IL-11, IL-15 and CCL5)
were found to be cytokine-independent (see Additional
file 6: Table S6), indicating that the expression of some
cytokines and chemokines likely occurs as part of the pri-
mary response to T. cruzi. Others, such as IL-6, appear to
be upregulated in response to diffusible molecules in par-
asite-infected cultures.
T. cruzi alters expression of host cell metabolic and 
signaling pathways in a cytokine-independent manner
To uncover a cytokine-independent signature response to
T. cruzi that is shared by diverse host cell types, we identi-
fied metabolic and signaling pathways that are signifi-
cantly modulated in response to infection after filtering
out the cytokine-dependent genes (Figure 3A). In general,
little overlap was observed in host cell pathways found to
be significantly perturbed in T. cruzi-infected HFF and
HMVEC (Figure 3A). However, pathways involving
"valine, leucine and isoleucine degradation", "ephrin
receptor signaling" and "PI3/AKT signaling" were simi-
larly altered in both T. cruzi-infected HFF and HMVEC
(Figure 3A). Several enzymes in the valine, leucine and
isoleucine degradation pathway were downregulated in
both cell types including BCAT2, which catalyzes the first
step in the degradation of branched chain amino acids
[37]. In the PI-3 kinase signaling pathway, two negative
regulators of Akt, PP2A and CTMP were downregulated in
infected fibroblasts and endothelial cells, as was TSC2, a
negative regulator of the mTOR pathway. In the ephrin
receptor signaling pathway, upregulation of growth fac-
tors such as FGF, PDGF and VEGF that signal through
receptor tyrosine kinases and repression of heterotrimericBMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
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Differential gene expression in T. cruzi-infected HFF, HMVEC and VSMC at 24 hours post-infection Figure 1
Differential gene expression in T. cruzi-infected HFF, HMVEC and VSMC at 24 hours post-infection. A. Heat map 
of genes modulated during T. cruzi infection in each cell line identified by hybridization to HG_U133 2.0 arrays and analyzed 
with Rosetta Resolver. Genes modulated (≥ 2-fold, p < 0.01) in at least one of the three cell types are shown. B. Venn diagrams 
comparing up or downregulated genes (≥ 2-fold, p < 0.01) and GO functions (p < 0.05) in each cell type. C. qPCR analysis of 
the expression of interferon beta (IFN-β) mRNA normalized to GAPDH. D. Canonical pathways identified by Inguenuity Path-
way Analysis™ software as significantly altered (p < 0.05) following T. cruzi infection of HFF, HMVEC and VSMC.BMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
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Identification of cytokine-dependent and – independent transcriptional responses in T. cruzi-infected HFF and HMVEC Figure 2
Identification of cytokine-dependent and – independent transcriptional responses in T. cruzi-infected HFF and 
HMVEC. A. Schematic showing experimental design where T. cruzi-infected cells on the bottom of the transwell plate are 
separated from uninfected cells on the top layer and mock-infected controls. B. Heat maps showing combined information for 
two replicate experiments for changes in transcript abundance (≥ 2-fold, p < 0.01) for cells plated in the bottom and top the 
top Transwell insert and for the genes remaining after subtraction of the genes present in both top and bottom (Methods). 
Black bars represent cytokine-dependent genes removed by filtering the top response from the bottom. C. qPCR confirmation 
of microarray data for selected non-differentially expressed genes (C), IFN-stimulated genes (ISG) and presumptive cytokine-
independent genes (cytokine-independent) identified by microarray analysis of samples obtained from HFF cells in Transwell 
experiments. Where more than one sequence corresponding to the same gene was modulated in the microarray data, the per-
fect match (_at) sequence was chosen. Tropomodulin 3 (TMOD 3), IFNβ (IFN-β), radical S-adenosyl methionine domain-con-
taining protein 2 (RSAD2), signal transducer and activator of transcription 1 (STAT-1), cholesterol-25-hydroxylase (CH25H), 
kruppel-like transcription factor-4 (KLF4), purine nucleoside phosphorylase (PNP), solute carrier family 39 member 8 
(SLC39A8), sphingosine kinase-1 (SPHK1), huntingtin-interacting protein 1-related protein (HIP1R), phosphofructokinase 
(PFK), myocardin (MYOCD). cDNA generated from three independent infections was analyzed and the mean fold-change ± 
s.d. are reported for the qPCR.BMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
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G proteins in HFF whereas in HMVEC, there is a trend
toward downregulation of growth factor signaling path-
ways and a similar repression of heterotrimeric G pro-
teins.
A set of 500 genes was found to be commonly altered in a
cytokine-independent manner in response to T. cruzi
infection of HFF and HMVEC (Figure 3B; genes) which
was represented by 59 GO function categories (Figure 3B;
GO functions) (see Additional file 9: Table S9). The top
functional categories associated with upregulated genes in
HFF and HMVEC included 'immune response' and
'response to wounding' (see Additional file 10: Table S10
for genes). To extend our analysis of shared host cell
responses to T. cruzi, we next considered transcriptional
response data for VSMC despite the lack of transwell data
for this cell type. Intersection of VSMC expression data
with cytokine-independent genesets from HFF and
HMVEC reveals only 37 genes (33 induced; 4 repressed)
that are commonly modulated in the three cell types fol-
lowing infection with T. cruzi (Table 1). In addition to
strong expression of IFNβ and CCL5 in all cell types, par-
asite infection induces the expression of genes involved in
cell-matrix interactions (osteopontin; SPP1) carbohydrate
modification (B4GT5 and B3GNT2), vesicular transport
SYTL3 and T-SNARE1 and Ca2+ homeostasis STIM1 and
CARKL (Table 1). In terms of common metabolic genes,
pantothenate kinase 2 (PANK2), the first enzyme in the
Cellular processes predicted by microarray data to be modulated during T. cruzi infection Figure 3
Cellular processes predicted by microarray data to be modulated during T. cruzi infection. A. Canonical pathways 
in T. cruzi-infected cells that are significantly modulated in a cytokine-independent manner. B. Venn diagrams comparing genes 
and representative GO functions for all up or downregulated genes (p < 0.05) in VSMC or following subtraction of the 
cytokine-dependent genes identified in the transwell experiments for HFF and HMVEC.BMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
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Table 1: Common cytokine-independent gene expression changes in T. cruzi-infected cells.
Name Sequence Description Accession HFF Fold HFF
p-value
HMVEC Fold HMVEC
p-value
VSMC Fold* VSMC
p-value*
IFNB1 Interferon, beta 1, fibroblast 100 0.00E+00 98.6 4.50E-27 11.4 3.11E-06
CCL5 Chemokine (C-C motif) ligand 5 AF043341 71.0 9.13E-35 57.1 4.53E-19 36 5.38E-19
CCL5 Chemokine (C-C motif) ligand 5 M21121 35.9 4.30E-16 58.2 4.53E-08 36.7 2.23E-15
CCL5 Chemokine (C-C motif) ligand 5 33.5 1.96E-25 92.0 8.48E-16 27.4 1.00E-13
LOC126520 Hypothetical protein AK054808 27.9 9.07E-18 11.4 8.23E-14 6.7 3.00E-05
215941_at MRNA, Xq terminal portion D16471 10.6 8.07E-07 9.1 8.84E-14 9.9 4.30E-08
LOC400740 Hypothetical gene AW205774 10.4 6.68E-11 5.1 1.08E-03 6 8.50E-04
ZBTB7A Zinc finger and BTB domain 
containing 7A
AI568395 8.8 3.20E-15 17.3 8.61E-19 11 6.11E-06
SSH2 Slingshot homolog 2 (Drosophila) AB072358 8.4 5.85E-10 8.5 8.02E-08 5.6 1.57E-03
CARKL Homo sapiens carbohydrate 
kinase-like (CARKL)
8.4 4.72E-08 9.0 4.64E-08 4.5 6.80E-03
1565716_at GN0053 Homo sapiens cDNA, 
mRNA sequence.
BE930017 7.9 3.38E-18 10.1 2.29E-14 4.2 3.00E-05
SLC24A4 SLC family 24 (sodium/potassium/
calcium exchanger), member 4
W90718 7.4 1.02E-08 4.7 2.95E-06 5.9 5.20E-04
LOC283761 Hypothetical protein BC039350 6.5 3.30E-04 15.3 2.20E-08 11 4.57E-06
SYTL3 Synaptotagmin-like 3 AI990716 6.5 1.47E-06 4.8 1.00E-05 4.3 4.67E-03
FLJ35390 Hypothetical protein BC024303 6.4 2.22E-10 6.2 3.83E-07 2.8 3.35E-03
IL17RE Similar to contains element TAR1 
repetitive element
AW003256 6.1 1.45E-06 3.4 2.74E-03 4.7 8.01E-03
SIM2 Single-minded (Drosophila) 
homolog 2 short isoform
5.8 7.69E-03 7.1 8.47E-06 6.8 1.48E-03
FLJ14213 Hypothetical protein AV732741 4.8 4.02E-03 6.6 2.50E-04 10.3 1.10E-04
231673_at Transcribed locus AW273730 4.7 7.94E-06 5.6 3.00E-05 2.7 7.29E-03
TSNARE1 T-SNARE domain containing 1 AI741779 4.6 7.19E-13 3.5 8.00E-05 3.8 3.00E-05
234510_at cDNA clone DKFZp566F133 AL049357 4.0 6.70E-04 4.2 9.00E-05 4.7 3.71E-03
PANK2 Pantothenate kinase 2 AV703394 3.5 9.91E-08 3.7 2.78E-03 2.1 7.06E-03
B3GNT2 beta-1,3-N-
acetylglucosaminyltransferase
3.4 2.77E-09 2.9 3.56E-03 2.1 3.00E-05
241657_at Transcribed locus AI791835 3.3 1.21E-03 4.4 8.50E-04 3.7 8.99E-03BMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
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biosynthetic pathway for coenzyme A production, was
upregulated in these diverse cell types in response to T.
cruzi-infection. While these genes do not assemble into
common metabolic or signaling pathways, examination
of significant GO terms indicate that the most basic com-
mon features of the host cell response to T. cruzi infection
of fibroblasts, endothelial cells and smooth muscle cells
involve the induction of stress response genes and those
involved in cell growth and proliferation (Table 2).
T. cruzi infection impedes late mitotic events
GO function analysis of genes that are downregulated in
T. cruzi-infected HFF and HMVEC in a cytokine-independ-
ent manner, reveal a significant bias toward 'mitotic cell
cycle', 'M phase', and 'cell division' (see Additional file 9:
Table S9), suggesting the possibility that T. cruzi infection
negatively impacts the host cell cycle. To further character-
ize this finding, markers of cell cycle progression were
evaluated in T. cruzi-infected cells. We first examined the
relative ability of infected cells to incorporate BrdU into
nuclear DNA (marking S-phase) by immunofluorescence
microscopy where parasite-containing and parasite-free
cells were scored separately. T. cruzi-containing cells
incorporate BrdU into nuclear DNA at levels similar to
mock-infected controls at 24 hours and by 48 hr post-
infection, twice as many infected cells were positive for
BrdU (~40%) as compared to controls (~20%) (Figure
4A) revealing that parasite infection does not impair cell
entry into S-phase. Given that this increase was observed
in both uninfected and parasite-containing cells in the
monolayer (Figure 4A, 48 hr) suggests the presence of a
soluble 'mitogen' in infected cell cultures that stimulates
DNA replication in neighboring uninfected cells. In con-
trast, by 72 hr post-infection nuclear BrdU incorporation
was shown to be minimal in parasite-infected cells where
increases in incorporation were found to be refractory to
EGF stimulation (Figure 4A, 72 hr). However, the unin-
fected cells in the population were still able to respond to
EGF with increased BrdU incorporation relative to para-
site-containing cells. These data suggest that following an
increase in cell cycle progression, a parasite-specific block
STIM1 Stromal interaction molecule 1 BC016014 3.1 2.30E-04 3.9 1.51E-08 2.6 4.81E-03
KLF4 Kruppel-like factor 4 BF514079 3.1 1.74E-08 8.2 1.04E-03 3.4 2.20E-07
HIST1H2AJ H2A histone family, member E 3.1 1.22E-09 4.7 1.85E-09 2.1 2.40E-04
HIST1H2AI H2A histone family, member C 3.0 2.69E-07 4.9 5.39E-08 2.1 4.60E-04
FNDC3A Cytochrome c oxidase subunit VIIc 
pseudogene 1
AL137000 2.8 5.61E-08 2.2 2.59E-03 2.3 4.03E-06
B4GALT5 beta 1,4-galactosyltransferase 
polypeptide 5
AL035683 2.8 4.55E-24 2.0 1.60E-10 2.1 2.38E-08
SPP1 Secreted phosphoprotein 1 
(osteopontin)
M83248 2.6 6.17E-03 5.1 1.80E-04 3.1 4.40E-04
CD55 Decay accelerating factor for 
complement
2.5 2.00E-05 2.2 9.37E-06 2.2 2.05E-06
LYSMD2 LysM, putative peptidoglycan-
binding, domain containing 2
AI674731 2.1 3.00E-05 3.5 3.58E-25 2.9 1.00E-05
PTPN11 Protein tyrosine phosphatase, non-
receptor type 11
L07527 -2.3 7.47E-03 -5.2 7.40E-04 -2.2 1.04E-03
PKP4 Plakophilin 4 -2.5 4.14E-08 -2.4 4.80E-04 -2 1.60E-07
MGC52110 hypothetical protein MGC52110 BF195431 -4.0 1.01E-06 -4.9 7.67E-06 -2.3 4.33E-03
MYT1 Myelin transcription factor 1 AB028973 -5.3 2.37E-16 -4.4 6.57E-06 -2.1 5.52E-03
Gene expression changes occurring in human vascular smooth muscle cells 24 hours after infection with T. cruzi. The data shown corresponds to 
probes for transcripts showing an intensity increase of 2-fold or greater (p < 0.01) with respect to their matched controls according to the analysis 
with Rosetta Resolver Biosoftware 7.0. *Transwell data not available for VSMC.
Table 1: Common cytokine-independent gene expression changes in T. cruzi-infected cells. (Continued)BMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
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on cell cycle progression occurs somewhere between 48
and 72 hr post-infection.
The ability to label host cell nuclei with anti-phospho-H3
at 48 hours post-infection (Figure 4B) indicates that T.
cruzi-infected cells are not blocked at the G2/M phase.
However, in 48 and 72 hour cultures T. cruzi-infected cells
containing 2, 3 or 4 nuclei were observed (Figure 4C)
where the multinucleate phenotype was strictly observed
in parasite-containing cells in the infected cultures. No
multinucleate cells were observed in mock-infected con-
trol populations at any time point (data not shown).
Because multinucleate cells can arise as a result of a block
in cytokinesis following nuclear division or via cell-to-cell
fusion, fluorescently labeled cells were used to distinguish
between these possibilities. Cells labeled with
Cytotracker-green or Cytotracker-orange were infected in
separate dishes for 2 hours then mixed in a 1:1 ratio and
infection was allowed to progress for 48 and 72 hours.
Parasite-containing multinucleate cells were either green
or orange as shown in the representative images (Figure
4C). No yellow cells, indicating that fusion had occurred,
were observed under any condition. These data indicate
that the multinucleate cells arose from rounds of nuclear
duplication without cytokinesis, demonstrating the inhib-
itory effect of T. cruzi infection on the late stages of host
cell division as predicted from the results of the microar-
ray analysis.
Discussion
Perturbation of host metabolic pathways and cellular
functions following pathogen infection is predicted to
result in compensatory changes in the expression of key
regulatory components in at least some of the affected
pathways. To facilitate elucidation of these critical func-
tions in T. cruzi-infected host cells, we identified a core
transcriptional response elicited in phenotypically diverse
cell types following intracellular infection with this path-
ogen. A subset of host cell genes for which expression was
similarly modulated in three different human cell types
was identified in dermal fibroblasts, microvascular
endothelial, and vascular smooth muscle, following infec-
tion with T. cruzi. Within this subset of genes we find that
interferon-stimulated genes (ISGs) are among the most
highly induced by T. cruzi in the three cell types. This find-
ing is consistent with previous observations that T. cruzi
triggers IFNβ expression in fibroblasts [38], macrophages
and dendritic cells [39] and reveals the robust nature of
the cytokine-driven response in shaping the early tran-
scriptional profile to this pathogen. In the second phase of
the study, transwell plates were employed to experimen-
tally distinguish cytokine-dependent and -independent
responses elicited in T. cruzi-infected cells. This applica-
tion permitted the identification of metabolic pathways
and cellular processes that were significantly altered by
the infective process in a cytokine-independent manner,
enabling us to focus on host cell transcriptional changes
that relate more directly to the metabolic impact of intra-
cellular parasitism.
Table 2: Cytokine-independent biological functions modulated during T. cruzi infection.
HFF
p-value
HFF
# genes
HMVEC
p-value
HMVEC
# genes
VSMC
p-value
VSMC
# genes*
UPREGULATED
GO CATEGORY
GO:9611: response to wounding 9.88E-09 29 9.25E-05 17 2.18E-05 17
GO:6955: immune response 1.02E-06 40 8.60E-05 27 2.01E-32 64
GO:42127: regulation of cell proliferation 1.76E-06 24 4.50E-04 15 4.37E-04 14
GO:6950: response to stress 1.45E-04 44 4.23E-05 35 6.12E-13 48
GO:6915: apoptosis 8.56E-03 24 1.38E-04 23 3.06E-03 18
DOWNREGULATED
GO CATEGORY
GO:7049: cell cycle 1.08E-05 78 2.03E-05 77 - - - -
GO:6412: protein biosynthesis 1.51E-02 48 2.57E-02 47 - - - -
Shown are selected GO functions modulated (p < 0.05, overlap ≥ 5 genes) in a cytokine-independent fashion 24 hours after T. cruzi 
infection.*Transwell data was not available for VSMC.BMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
Page 10 of 17
(page number not for citation purposes)
Host transcriptional responses to T. cruzi become detecta-
ble at 24 hours post infection [38] which reflect the cumu-
lative pre- and post-invasion events including
differentiation of the invasive T. cruzi trypomastigotes to
replicative amastigotes located in the host cell cytoplasm.
It is predicted that these activities are responsible for a
subset of the cytokine-independent changes in expression
of host biosynthetic pathways such as those that would
favor utilization of metabolites by the parasite. For exam-
ple, in parasite-infected fibroblasts, endothelial cells and
smooth muscle cells we observe upregulation of host 5'-
nucleotidase and/or purine nucleoside phosphorylase
(PNP), which generate the purine nucleosides and purine
bases [40]. Given that T. cruzi is reliant on purine salvage
for growth [41], induction of purine catabolic enzymes in
infected host cells may directly benefit replicating para-
sites. Along these lines, where T. cruzi is incapable of syn-
thesizing the aliphatic amino acids, leucine, isoleucine
and valine [36], we have observed a general repression of
the valine, leucine and isoleucine degradation pathway,
including expression of the first enzyme in the catabolic
pathway, BCAT2. Inhibiting the breakdown of these
amino acids would presumably increase their cellular
concentration and opportunities for scavenging by the
parasite. Another gene of interest, upregulated in diverse
cell types in response to T. cruzi, is PANK2, that encodes
pantothenate kinase 2, the first enzyme in the biosyn-
thetic pathway for Coenzyme A production [42]. Given
that CoA is required for GPI anchor synthesis, which is the
modification of choice for T. cruzi surface glycoproteins, it
Cell cycle progression of T. cruzi-infected cells Figure 4
Cell cycle progression of T. cruzi-infected cells. A. Quantitation of BrdU-stained HFF cells mock- or T. cruzi-infected in 
the presence or absence of 5 ng/ml EGF for 24, 48 or 72 hours. Within infected cultures, parasite-containing and parasite-free 
cells were scored separately. B. Phospho-H3 staining (green) in T. cruzi-infected cells at 48 hours post-infection where host 
and parasite DNA are stained with DAPI (blue). C. Images of co-cultured T. cruzi-infected HFF cells preloaded with 
Cytotracker™-green (green) or Cytracker™-orange (red). Host cell nuclei (N) and parasite DNA (smaller blue) are stained 
with DAPI (blue).BMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
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is tempting to speculate that by co-opting host CoA or one
of its precursors, the parasite creates an increased demand
for CoA which is met by upregulating this key enzyme in
the host cell CoA biosynthetic pathway.
In addition to potential changes in host cell biosynthetic
activities, the expression of apoptotic regulators and stim-
ulators of cell proliferation were also significantly induced
in T. cruzi-infected cells. This observation is interesting in
light of data showing that T. cruzi infection protects cardi-
omyocytes and neuronal cells from apoptotic stimuli
[43,44]. Moreover, parasite-mediated protection from cell
death appears independent of diffusible molecules
released from infected host cells [44], consistent with the
observed modulation of the expression of apoptosis regu-
lators in a 'cytokine-independent' manner in this study.
While the mechanistic basis for the apoptotic block is cur-
rently not known, alteration of expression of host cell
genes related to apoptosis is likely to benefit the parasite
by preventing host cell death before the intracellular rep-
licative cycle is complete.
Despite commonalities observed in the early response of
diverse host cell types to T. cruzi, a minor fraction of host
metabolic and signaling pathways were found to be
shared by T. cruzi-infected fibroblasts, endothelial and
smooth muscle cells. Intrinsic differences in the levels of
available host cell metabolic intermediates might be a
determining factor in the activation of homeostatic mech-
anisms and associated transcriptional changes. In addi-
tion to absolute differences between cell types, kinetic
differences in the cellular response to metabolic pressures
exerted by intracellular parasites may also produce non-
overlapping responses at a given time-point. In our study,
which examined only 24 hours post-infection, VSMC
were found to respond with relatively few changes in tran-
script abundance as compared to HFF or HMVEC, despite
similar burden of intracellular parasites. A comparison of
canonical pathways altered in VSMC at 48 hr post-infec-
tion (for which there were >2000 genes as compared to
~500 observed at 24 hours, see Additional file 11: Table
S11) with the cytokine-independent response triggered in
HFF and HMVEC revealed an increase in the number of
overlapping pathways (not shown). This observation sug-
gests that cell type specific responses to T. cruzi include a
kinetic component that influences the timing for which
significant changes are observed in an infected cell type. In
general, presumptive compensatory changes in host cell
genes involved in certain metabolic processes: eg. purine
metabolism, aliphatic amino acid catabolism, cell growth
and anti-apoptosis might have been predicted based on
our knowledge of T. cruzi physiology and interactions of
the parasite with the host cell. However, our array analysis
also predicted the unexpected finding that T. cruzi infec-
tion might impede cell cycle progression, on the basis that
the top GO terms associated with downregulated
cytokine-independent genes in HFF and HMVEC were
associated with mitosis and cell division. While the
impact of T. cruzi on cellular proliferation genes has been
noted in a previous microarray study of T. cruzi-infected
HeLa cells at 72 hours post-infection [45], no conclusions
were drawn as to the impact of these changes on cellular
proliferation. Here, we have demonstrated that T. cruzi-
infected fibroblasts are capable of DNA synthesis and
nuclear replication, but exhibit abortive cytokinesis as
judged by an accumulation of multinucleate cells at 48
and 72 hours post-infection. The increased level of BrdU
incorporation observed in both parasite-containing and
parasite-free cells in infected monolayers at 48 hours post-
infection suggest that infection with T. cruzi potentiates
host cell DNA synthesis early in the infective process and,
secondly, that this may be mediated by a soluble factor in
the medium. These findings are consistent with the obser-
vation that a number of growth factor genes (FGF, PDGF,
VEGF) are upregulated in infected fibroblasts at 24 hours
post-infection and that 'cellular proliferation' features as
one of the overrepresented GO terms for upregulated
genes in T. cruzi-infected HFF, HMVEC and VSMC.
The mechanistic basis for the block in cell division is cur-
rently unknown, but it may be linked to a general damp-
ening of key cytoskeletal genes that would be required for
cytokinesis, including septins and several actin regulatory
genes (ARPC1A, DLG1, FARP1, MYH10, WIRE) as well as
induction of the protein phosphatase slingshot-2 (SSH2)
in infected cells which promotes actin disassembly via the
activation of cofilin [46]. Related to these findings, we
have recently demonstrated that the mechanical proper-
ties of T. cruzi infected cells change significantly with
infected cells becoming less stiff over the course of a 72
hour infection in a manner that appears to be related to
decreased Rho kinase activity in infected cells [47]. While
the significance of these findings is presently unclear, it is
possible that inhibition of host cell division provides a
more favorable environment for nutrient acquisition by
the intracellular parasites. It should be noted that some of
the important in vivo targets of T. cruzi infection, cardio-
myocytes for example, are terminally differentiated cells
that are no longer undergo mitosis. It has also been dem-
onstrated that mitotic cells are relatively refractory to
infection in vitro [48]. While there are many potential rea-
sons for this observation, including the dramatic reorgan-
ization of microtubules and reduced vesicular trafficking
that occurs during this stage of the cell cycle [49], the col-
lective set of observations are reflective of the important
interplay between host cell cycle and T. cruzi infection.
Several intracellular parasites are known to impinge on
host cellular proliferation pathways where Leishmania
amazonensis and Toxoplasma gondii block host cell cycle
progression at the G1/S transition [50] and G2/M stagesBMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
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[51,52], respectively. In contrast, Theileria parva promotes
uncontrolled proliferation of infected host lymphocytes
[53]. The ability of Toxoplasma to block cell cycle progres-
sion was associated with the induction of host UHRF1
protein (ubiquitin-like, containing PHD and RING finger
domains 1), the suppression of which by siRNA blocks
both G2 arrest and reduces parasite proliferation in the
host cell [52]. A similar induction of UHFR1 mRNA is not
observed at 24 hours post-infection at any of the cell types
infected with T. cruzi, consistent with the observation that
this parasite does not impede cycles of DNA replication
and nuclear division, but instead, appears to dysregulate
aspects of cytokinesis. Additional studies will be instru-
mental for elucidation of the mechanism of T. cruzi-medi-
ated interruption of the host cell cycle and to determine
the benefits, if any, to host and pathogen. Such studies
could include transcriptional profiling of other cell types,
including cardiomyocytes and other non-dividing cells,
which constitute important targets for T. cruzi infection,
and would provide a contrasting view with respect to the
cells that were examined here. Furthermore, although the
cell cycle progression analysis was performed in cell cul-
tures that had reached confluence 48 hours prior the
experiments and demonstrated to be were arrested in G0
(data not shown), future global transcriptional profiling
of synchronized cells could more clearly define the mod-
ulation of cell cycle-related genes. Prior to this study, there
was no indication in the literature that T. cruzi can block
host cell division. The novel findings, reported here, dem-
onstrate the utility of transcriptional profiling in directing
the rational search for host biological functions affected
during pathogen intracellular infection.
In summary, we have uncovered novel host cell physiol-
ogy secondary to parasite infection that is cytokine-inde-
pendent, including evidence for parasite induced host cell
cycle arrest. Given that we have limited knowledge of the
intracellular requirements for T. cruzi amastigote replica-
tion and survival, the parasite-modulated pathways iden-
tified here represent potential targets for further
functional analysis and intervention.
Conclusion
With the goal of expanding the current understanding of
intracellular requirements of T. cruzi and the host path-
ways and processes that support its intracellular growth,
an experimental approach that combined transcriptional
profiling and transwell culture systems was employed in
this study. A core set of host transcriptional changes elic-
ited directly (independently from soluble factors, i.e.
'cytokines') by intracellular infection with T. cruzi in three
different human cell types was unveiled (summarized in
Figure 5). Common responses include metabolic and sig-
naling pathways involved in cell proliferation, amino acid
catabolism and response to wounding. The transcrip-
tional profiles also suggested the blockage of the cell cycle
progression due to parasite infection in two out of the
three studied cell types, a novel finding that was experi-
mentally confirmed as infected cells demonstrated a fail-
ure to undergo cytokinesis. The experimental approach
employed in this study is a valid tool to unveil biological
events triggered directly by the presence of intracellular
microorganisms, without the mediation of soluble fac-
tors.
Methods
Cell line and parasite maintenance
LLcMK2 cells and human foreskin fibroblasts (HFF) were
maintained in DMEM supplemented with 10% fetal
bovine serum (FBS), 2 mM glutamine, 100 U/ml penicil-
lin and 100 μg/ml streptomycin. Human vascular smooth
muscle cells (VSMC) were grown in Ham's F12K medium
with 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 10
mM HEPES, 10 mM TES, 0.05 mg/ml ascorbic acid, 0.001
mg/ml insulin, 0.01 mg/ml transferrin, 10 ng/ml sodium
selenite, 0.03 mg/ml endothelial cell growth supplement
(ECGS) and 10% FBS. Human cardiac microvascular
endothelial cells (HMVEC) were maintained in endothe-
lial cell basal medium-2 and endothelial cell growth sup-
plements (Cambrex Bio Science) including 5% FBS. Y-
strain T. cruzi trypomastigotes were maintained by serial
passage in LLcMK2 cells as previously described [54].
Summary of common and cell specific responses elicited in  human cells infected with T. cruzi Figure 5
Summary of common and cell specific responses elic-
ited in human cells infected with T. cruzi. Common 
transcriptional responses are shown inside the circle, while 
individual responses are shown in the outside, next to each 
cell type. Transwell data was not available for VSMC. Arrows 
indicate up or downregulation.BMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
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Experimental T. cruzi infection
To achieve 80% confluence 48 hrs post-plating VSMC
were seeded at a density of 2 × 105 cells/10 cm dish. For
Transwell experiments, the lower wells of 10 cm Transwell
plates (Corning Inc; 3 μm pore size) were seeded at a den-
sity of 2 × 105 cells/dish (HFF) or 4 × 105 cells/dish
(HMVEC) with half the amount, respectively, plated in
the upper chamber. VSMC or HFF/HMVEC in the lower
chamber of Transwell were infected for 2 hours with 1 ×
108/ml trypomastigotes at 37°C in a CO2 incubator in the
appropriate growth medium for each cell type supple-
mented with 2% FBS. Extracellular parasites were aspi-
rated, and infected monolayers rinsed 5 times with PBS
before incubation in complete growth medium (10% FBS
for VSMC and HFF and 5% FBS for HMVECs) for the indi-
cated times. To monitor infection levels, sterile 12 mm2
coverslips, placed in dishes prior to cell seeding, were
removed, fixed in 2% w/v paraformaldehyde/PBS and
immunostained as described [30]. Control monolayers
were mock-infected in 2% FBS medium and submitted to
the same washing steps as the experimental infections.
RNA extraction
Cell monolayers were rinsed 3 times with sterile PBS and
total RNA was isolated with Trizol reagent (Invitrogen) in
accordance with the manufacturer's instructions and con-
centrated using the RNeasy kit (Quiagen). RNA was quan-
titated spectrophotometrically in a Beckman DU 530
spectrophotometer and stored at -80°C.
Microarray hybridization and analysis
RNA quality control and microarray hybridization was
performed at the at the Harvard Medical School's Biopol-
ymers facility. RNA integrity was evaluated employing an
Agilent 2100 Bioanalyzer (Agilent Technologies), and 5
μg of each sample were processed and hybridized onto
HG_U133 plus 2.0 Affymetrix chips, according to manu-
facturer's specifications for One-Cycle Target labeling
Assay. Data acquisition performed in a GeneChip® Scan-
ner 3000 (Affymetrix). The Affymetrix data files contain-
ing the unprocessed intensity values (i.e. Affymetrix .cel
files) were imported into Rosetta Resolver Biosoftware 7.0
where the data was pre-processed to reduce systematic
errors (i.e. background subtraction and intra-array nor-
malization). Through the application of the Affymetrix-
specific error model within Rosetta Resolver [55], the data
were transformed into profiles (i.e. scanned, imaged and
normalized expression data). Intensity ratios were calcu-
lated from the statistical combination of replicate profiles
in order to increase the confidence in measurements, and
to obtain fold-change values and associated ρ-values.
Transcripts showing at least a 2-fold change (ρ < 0.01)
with respect to their matched controls were used to create
gene lists that were subsequently uploaded into Gene-
spring GX gene expression analysis software (Agilent
Technologies) to generate heat maps and perform GO
function analysis or into Ingenuity Pathway Analysis™
(IPA) (Ingenuity Systems Inc.) software to identify meta-
bolic and signaling pathways. Redundant probes (more
than one probe corresponding to the same gene) within
the gene sets employed in the GO function analysis were
manually removed to avoid inflating the overlap with GO
categories. In accordance to the minimum information
about microarray experiment (MIAME) guidelines, the
complete raw and processed data files for each array are
publicly available at the Gene Expression Omnibus
(GEO) database repository http://www.ncbi.nlm.nih.gov/
geo/ [GEO: GSE13791].
Quantitative RT-PCR
Total RNA was treated with DNAse (Invitrogen) and
reverse transcribed using the Iscript kit (Bio Rad). Quanti-
tative PCR was performed in a 7300 real-time PCR system
(Applied Biosystems) using real time PCR mastermix
(ABI). Specific primers and FAM-labeled probes for each
gene of interest were purchased as inventoried assays from
Applied Biosystems. ΔΔCT values were calculated with
respect to VIC-labeled human GAPDH controls (ABI) and
data is represented as fold-change for individual genes
under experimental (infection, exposure to soluble fac-
tors) relative to mock-infected control cells. The samples
employed for the qPCR analysis included the same sam-
ples used in experiments analyzed by DNA microarray
hybridization as well as additional independent experi-
ments.
Quantification of cytokine production by infected cells
HFFs, HMVECs and VSMC were seeded in six-well plates
and mock/infected as described above. Aliquots of 120 μl
of medium were taken every 6 hours, filter sterilized and
analyzed using SearchLight custom Multiplex arrays
(Pierce Biotechnology Inc.).
Cell cycle progression analysis
Cells were seeded into two 6-well plates, allowed to grow
and reach confluence for 48 hours prior to being mock/
infected as described above. FACS analysis of propidium
iodide stained cells showed that this strategy induced the
arrest of most of the cell population into Go phase of the
cell cycle. Six hours post infection the cells were re-split
into 6-wells containing sterile cover slips at a 1:4 ratio and
allowed to re-attach for 12 hours. To monitor entry into S-
phase, cover slips were stained with BrdU using the in situ
cell proliferation kit FLUOS (Roche) according to manu-
facturer's instructions. Parasite and host cell DNA was
counterstained with propidium iodide prior to mounting
the slides with Mowiol. To evaluate progression into M-
phase, fixed cells were, stained with anti-human phospho-
histone H3 (Ser 10) antibody (Cell Signaling Technology)
and host cell and parasite DNA were counterstained withBMC Genomics 2009, 10:252 http://www.biomedcentral.com/1471-2164/10/252
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DAPI. Images were obtained with a CCD camera mounted
on a Nikon TE-300 epifluorescescence microscope and
analyzed employing MetaMorph software (Universal
Imaging Corporation).
Cell fusion experiment
HFFs were seeded into two 6-well plates, allowed to grow
for 48 hours and mock/infected as described above. Six
hours post-infection, each plate was loaded with 5 μM of
either Cytotracker™ green or Cytotracker™orange dye (Inv-
itrogen) for 45 minutes in accordance with manufac-
turer's instructions. The cells were then trypsinized, green
and orange dyed cells were mixed, and plated into 6-well
plates containing sterile cover slips at one fourth the den-
sity of the original cultures. At 24, 48 and 72 hours, post
infection, cover slips were removed, fixed with 3.7% for-
maldehyde in PBS for 15 minutes, counterstained with
DAPI, mounted with MOWIOL and visualized as
described above.
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Additional material
Additional file 1
Table S1 – Gene expression changes in T. cruzi-infected VSMC 24 hr. 
Gene expression changes occurring in human vascular smooth muscle cells 
24 hours after infection with T. cruzi. The data shown corresponds to 
probes for transcripts showing an intensity increase or reduction of 2-fold 
or greater (p < 0.01) with respect to their matched controls according to 
the analysis with Rosetta Resolver Biosoftware 7.0.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-252-S1.xls]
Additional file 2
Table S2 – Gene expression changes in T. cruzi-infected HFF 24 hr. 
Gene expression changes occurring in human foreskin fibroblasts 24 hours 
after infection with T. cruzi. The data shown corresponds to probes for 
transcripts showing an intensity increase or reduction of 2-fold or greater 
(p < 0.01) with respect to their matched controls according to the analysis 
with Rosetta Resolver Biosoftware 7.0.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-252-S2.xls]
Additional file 3
Table S3 – Gene expression changes in T. cruzi-infected HMVEC 24 
hr. Gene expression changes occurring in human microvascular endothe-
lia cells 24 hours after infection with T. cruzi. The data shown corre-
sponds to probes for transcripts showing an intensity increase or reduction 
of 2-fold or greater (p < 0.01) with respect to their matched controls 
according to the analysis with Rosetta Resolver Biosoftware 7.0.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-252-S3.xls]
Additional file 4
Table S4 – T. cruzi-induced genes common to VSMC, HFF and 
HMVEC 24 hr. Gene expression changes at 24 hours after infection with 
T. cruzi that are common to human foreskin fibroblasts, human microv-
ascular endothelial cells and human vascular smooth muscle cells. The 
data shown corresponds to probes for transcripts that show an intensity 
increase of 2-fold or greater (p < 0.01) with respect to their matched con-
trols according to the analysis with Rosetta Resolver Biosoftware 7.0.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-252-S4.xls]
Additional file 5
Table S5 – GO function categories associated with T. cruzi-induced 
genes. Gene ontology analysis was performed using Genespring GX to 
identify functions with significant overlap (p < 0.05, overlap = 5 genes) 
with the genes upregulated in human foreskin fibroblasts, human micro-
vascular endothelial cells and human vascular smooth muscle cells 24 
hours after infection with T. cruzi. The functions induced in each cell type 
were intersected, and common functions are shown.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-252-S5.xls]
Additional file 6
Table S6 – Cytokine/chemokine genes upregulated in T. cruzi infected 
cells. Gene expression changes (2-fold or greater p < 0.01) occurring in 
each of the studied cell types for cytokine and chemokine genes with 
respect to their matched controls according to the analysis with Rosetta 
Resolver Biosoftware 7.0.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-252-S6.xls]
Additional file 7
Table S7 – 'Cytokine'-independent genes modulated by T. cruzi infec-
tion of HFF. Gene expression changes occurring in human foreskin 
fibroblasts 24 hours after infection with T. cruzi, after removal of genes 
induced by soluble factors through the use of transwells, as described in 
methods. The data shown corresponds to probes for transcripts showing an 
intensity increase or reduction of 2-fold or greater (p < 0.01) with respect 
to their matched controls according to the analysis with Rosetta Resolver 
Biosoftware 7.0.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-252-S7.xls]
Additional file 8
Table S8 – 'Cytokine'-independent genes modulated by T. cruzi infec-
tion of HMVEC. Gene expression changes occurring in human microvas-
cular endothelial cells 24 hours after infection with T. cruzi, after removal 
of genes induced by soluble factors through the use of transwells, as 
described in methods. The data shown corresponds to probes for transcripts 
showing an intensity increase or reduction of 2-fold or greater (p < 0.01) 
with respect to their matched controls according to the analysis with 
Rosetta Resolver Biosoftware 7.0.
Click here for file
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Table S9 – Common GO function categories for cytokine-independent 
responses in T. cruzi-infected HFF and HMVEC. Gene ontology analy-
sis was performed using Genespring GX to identify functions with signifi-
cant overlap (p < 0.05, overlap = 5 genes) with the genes up or 
downregulated in human foreskin fibroblasts or human microvascular 
endothelial cells 24 hours after infection with T. cruzi. The functions 
modulated in each cell type were intersected, and common functions are 
shown.
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